Ocera Therapeutics Receives Orphan Drug Status for AST-120 for...(et exclusivity of the product for seven ...),Health
Navigation Links
Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis
Date:1/7/2008
et exclusivity of the product for seven years, in addition to other incentives.
AST-120 was in-licensed from Kureha Corporation, Japan in 2005 and is currently being studied in a Phase 3 trial in Fistulizing Crohn's disease.
About Ocera Therapeutics, Inc.
Ocera Therapeutics, Inc. is a privately held biopharmaceutical company focused on the licensing, development and commercialization of proprietary compounds to treat a broad range of gastrointestinal and liver diseases. Ocera is based in San Diego and is pursuing the development of AST-120 in Crohn's disease, Pouchitis and conducting proof of concept trials in other gastrointestinal and liver diseases including, Hepatic Encephalopathy, Irritable Bowel Syndrome and Proton Pump Inhibitor-resistant Gastroesophageal Reflux Disease. Ocera Therapeutics has raised $26.5 million dollars in venture financing from Domain Associates, Sofinnova Ventures and Thomas, McNerney & Partners. Additional information on the Company can be found at http://www.oceratherapeutics.com.
For more information on Pouchitis, visit the Crohn's and Colitis
Foundation of America website at http://www.ccfa.org.
Media Contact: Company Contact:
Melissa Hill Laurent Fischer
Porter Novelli Life Sciences Ocera Therapeutics, Inc.
619-849-6004 858-436-3901
mhill@pnlifesciences.com lfischer@ocerainc.com
'/>"/>
| SOURCE Ocera Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. National Patient Safety Foundation Partners with Vocera Communications
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Post Your Comments:
(Date:11/21/2009)...ask whether there is a secret to ,alcohol rehab su... London, UK (PRWEB) November 21, 2009 -- Li... the adult UK population drinking enough alcohol t...r disease*, it is hardly a surprise that many are ...and residential centres for help. However, for som...
(Date:11/20/2009)...wswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. ...ders will be held on Monday, December 21, 2009. Th...f two special resolutions. The first special resol...or substantially all of the assets of NUCRYST, sub...purchase agreement dated November 10, 2009 among t...
(Date:11/20/2009)...ewswire-USNewswire/ -- The United States Conferenc...ential changes its health reform bill in order to ...conscience protection on abortion, protect access ...rovisions for adequate affordability. ,, The bi...ous disappointment" that creates new and unaccepta...
(Date:11/20/2009)...ongressmen in Competitive Re-election Battles Coul... Washington, DC (Vocus) Novemb...r re-election next year in races deemed to be comp...o regret voting for House Speaker Nancy Pelosi&rsq...by International/ O’Leary Report poll. (Th...
(Date:11/20/2009)...USNewswire/ -- The American Dental Association (AD...on (FDA) to establish appropriate classifications ...rn about the safety of whitening products that are...ional consultation or examination by a dentist, th...lly based tooth whitening or bleaching agents can ...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2[0] Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not[0] NUCRYST Announces Special Meeting of Shareholders[0] U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability[0] Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill [0] American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products
...coalition representing,skilled nursing facilities ...overnor Strickland,s budget proposal to cut Medica...s are increasing. Alan Melamed, spokesman for the,...aff,than they have in the past. However, the gover...
...ful when trying to spot fatigue , , MONDAY...or less tired? Focus on the area around your eyes,... get visual clues about your age and level of fati...ound. The number was about the same when the parti...
...b. 2 HLTH Corporation (Nasdaq: HLTH ) and its a...rp. (Nasdaq: WBMD ), today announced that they w... the three months ended December 31, 2008 at appro... , , Investors can access the call via webcast ...
... for America,s Health (TFAH) strongly supports Pre... nation,s food safety system. The latest outbreak ...addition to major E.coli and Salmonella outbre...Protecting America,s Food Supply from Farm-to-Fork...
...iotic, deadly bacteria can counter it by turning i...terial infection is the number one killer in hospi...ity may give drug developers the upper hand in out...s it to reduce its population through cannibalism....
...new girl in town and she made her American debut a...urgeon, Dr. Richard Rosenfield. ViKY, as she is af...t robot developed by EndoControl, headquartered in...ntly, the entire procedure was performed in an out...
Other Medicine News:Health News:State Budget Proposal Hurts Ability to Care for Most Vulnerable Ohioans 2Health News:When Gauging Age, the Eyes Have It 2Health News:HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call 2Health News:Trust for America's Health Applauds President Obama's Call for a Complete Review of the U.S. Food Safety System 2Health News:Trust for America's Health Applauds President Obama's Call for a Complete Review of the U.S. Food Safety System 3Health News:Can cannibalism fight infections? 2Health News:Can cannibalism fight infections? 3Health News:A World First in Minimally Invasive Robotic Surgery Promises a More Cost-Effective, Patiently Friendly Future 2Health News:A World First in Minimally Invasive Robotic Surgery Promises a More Cost-Effective, Patiently Friendly Future 3State Budget Proposal Hurts Ability to Care for Most Vulnerable OhioansWhen Gauging Age, the Eyes Have ItHLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference CallTrust for America's Health Applauds President Obama's Call for a Complete Review of the U.S. Food Safety SystemCan cannibalism fight infections?A World First in Minimally Invasive Robotic Surgery Promises a More Cost-Effective, Patiently Friendly Future
(Date:11/20/2009)...LOUISVILLE, Ky., Nov. 20 The Nat...(NADDI) today announced a new initiative in the wa...Exchange (NPLEx) is a multi-state electronic track...over-the-counter (OTC) medicines containing pseudo...technology for NPLEx is based on a system that was...
(Date:11/20/2009)... HARRISBURG, Pa., Nov. 20 /PRNewswire-USNewswire/ ...free H1N1 flu shots to members of priority groups ...,, A total of 18 clinics are being held statewi... p.m. to 8 p.m. Hours on Saturday, Nov. 21, will b... will operate from 2 p.m. to 8 p.m. ,, Individ...
(Date:11/20/2009)..., NEW YORK, Nov. 20 Reportlinker...s available in its catalogue. ,, Pipettes &... http://www.reportlinker.com/p0164373/Pipettes--Pi...rce=prnewswire&utm_medium=pr&utm_campaign=...ted as an integral part of any research laboratory...
Breaking Medicine Technology:National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12WuXi PharmaTech Schedules Second Quarter 2009 Earnings Release 13110 1WuXi PharmaTech Schedules Second Quarter 2009 Earnings Release 13110 2Gene linked to increasingly common type of blood cancer 52171 1Gene linked to increasingly common type of blood cancer 52171 2Gene linked to increasingly common type of blood cancer 52171 3Improving the science of systematic reviews 3A Introducing the PRISMA statement 52169 1[0] National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production[0] Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available[0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective
...las Pharma US, Inc. today,announced that the inves...ed conversion to normal heart rhythm (sinus rhythm... following coronary artery bypass,graft (CABG) or ...ndition,characterized by an irregular heart rhythm...sented at the annual meeting of the American Heart...
... into Phase 2 Bone Mineral Density Study in ...Nov. 7 Nastech Pharmaceutical,Company Inc. (Nasda...the,rights to teriparatide (Parathyroid Hormone; P...sis from its collaboration partner, Procter & Gamb... notification on Nov. 6,2007, of Procter & Gamble,...
Other Medicine Technology:Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery 2Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery 3Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble 2Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble 3Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |